Literature DB >> 11204459

Altered ornithine decarboxylase and S-adenosylmethionine decarboxylase expression and regulation in mouse fibroblasts transformed with oncogenes or constitutively active Mitogen-Activated Protein (MAP) kinase kinase.

R A Hurta1.   

Abstract

In the present study, the expression and the regulation of ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (SAMDC) was examined in a series of oncogene transformed cell lines. The expression of both ODC and SAMDC was found to correlate with the nature of the oncogene expressed and with the resulting cellular phenotype expressed. This study demonstrates, for the first time, that the expression of both ODC and SAMDC increases as a function of cellular transformation and, in particular, as a function of malignant progression. Ras transformed cells were shown to express a unique regulatory mechanism whereby a co-ordinate up-regulation of the expression of both ODC and SAMDC occurs (via post-transcriptional stabilization of their mRNA transcripts) in the presence of protein synthesis inhibition. Altered expression (and regulation) of both ODC and SAMDC is suggested to constitute an important part of an altered growth regulatory program inherent to oncogene transformed cells, in particular, to transformed cells capable of malignant progression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11204459     DOI: 10.1023/a:1026539414863

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.

Authors:  S E Egan; G A McClarty; L Jarolim; J A Wright; I Spiro; G Hager; A H Greenberg
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

2.  Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones.

Authors:  L Sistonen; J Keski-Oja; I Ulmanen; E Hölttä; B J Wikgren; K Alitalo
Journal:  Exp Cell Res       Date:  1987-02       Impact factor: 3.905

3.  Transformation of mammalian cells by constitutively active MAP kinase kinase.

Authors:  S J Mansour; W T Matten; A S Hermann; J M Candia; S Rong; K Fukasawa; G F Vande Woude; N G Ahn
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

4.  Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells.

Authors:  A Manni; R Wechter; S Gilmour; M F Verderame; D Mauger; L M Demers
Journal:  Int J Cancer       Date:  1997-01-17       Impact factor: 7.396

5.  Developmental expression of ornithine and S-adenosylmethionine decarboxylases in mouse brain.

Authors:  A Suorsa; O Hietala; A Pajunen
Journal:  Biochem Biophys Res Commun       Date:  1992-04-30       Impact factor: 3.575

6.  The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells.

Authors:  E Hölttä; L Sistonen; K Alitalo
Journal:  J Biol Chem       Date:  1988-03-25       Impact factor: 5.157

7.  Ornithine decarboxylase: an indicator for growth of NIH 3T3 fibroblasts and their c-Ha-ras transformants.

Authors:  A Shayovits; U Bachrach
Journal:  Biochim Biophys Acta       Date:  1995-06-20

Review 8.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

Review 9.  Ornithine decarboxylase as an enzyme target for therapy.

Authors:  P P McCann; A E Pegg
Journal:  Pharmacol Ther       Date:  1992       Impact factor: 12.310

Review 10.  Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy.

Authors:  A E Pegg
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

View more
  1 in total

1.  Transcriptional and translational control of ornithine decarboxylase during Ras transformation.

Authors:  Lisa M Shantz
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.